Search research articles
Contact Us
Filters
Showing results (31-40 of 85) with videos related to
Page
of 9
Sort By:
CA: a Cancer Journal for Clinicians
|
January 1, 1995
Chemoprevention
P Greenwald, G Kelloff, C Burch-Whitman, et al.
Cancer
|
January 15, 1993
A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers
B S Kramer, J Gohagan, P C Prorok, et al.
Cancer Treatment Reports
|
October 1, 1984
Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial
B S Kramer, R Gams, R Birch, et al.
Cancer Treatment Reports
|
August 1, 1986
Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial
B S Kramer, R Birch, A Greco, et al.
The Journal of Urology
|
November 1, 1994
Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute
J K Gohagan, P C Prorok, B S Kramer, et al.
Cancer Treatment Reports
|
June 1, 1986
Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial
B S Kramer, R Birch, J P Gockerman, et al.
Controlled Clinical Trials
|
February 24, 2001
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status
J K Gohagan, P C Prorok, R B Hayes, et al.
JAMA
|
February 15, 1995
The role of increasing detection in the rising incidence of prostate cancer
A L Potosky, B A Miller, P C Albertsen, et al.
Cancer Treatment and Research
|
January 1, 1996
Prostate cancer screening: current issues
P C Prorok, A L Potosky, J K Gohagan, et al.
International Journal of Cancer
|
February 1, 1991
Schedule-dependent in vitro combination effects of methotrexate and 5-fluorouracil in human tumor cell lines
C M Tsai, A F Gazdar, R P Perng, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 85) with videos related to
Sort By:
Page
of 9
CA: a Cancer Journal for Clinicians
|
January 1, 1995
Chemoprevention
P Greenwald, G Kelloff, C Burch-Whitman, et al.
Cancer
|
January 15, 1993
A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers
B S Kramer, J Gohagan, P C Prorok, et al.
Cancer Treatment Reports
|
October 1, 1984
Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial
B S Kramer, R Gams, R Birch, et al.
Cancer Treatment Reports
|
August 1, 1986
Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial
B S Kramer, R Birch, A Greco, et al.
The Journal of Urology
|
November 1, 1994
Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute
J K Gohagan, P C Prorok, B S Kramer, et al.
Cancer Treatment Reports
|
June 1, 1986
Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial
B S Kramer, R Birch, J P Gockerman, et al.
Controlled Clinical Trials
|
February 24, 2001
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status
J K Gohagan, P C Prorok, R B Hayes, et al.
JAMA
|
February 15, 1995
The role of increasing detection in the rising incidence of prostate cancer
A L Potosky, B A Miller, P C Albertsen, et al.
Cancer Treatment and Research
|
January 1, 1996
Prostate cancer screening: current issues
P C Prorok, A L Potosky, J K Gohagan, et al.
International Journal of Cancer
|
February 1, 1991
Schedule-dependent in vitro combination effects of methotrexate and 5-fluorouracil in human tumor cell lines
C M Tsai, A F Gazdar, R P Perng, et al.
Page
of 9